29 August 2018 - Surprise! The Trump administration is actually making progress to reduce drug prices, and not just by “browbeating” pharmaceutical executives.

The Centers for Medicare & Medicaid Services recently announced new options to increase competition for physician-administered drugs and lower the cost of some innovative medications, and the Food and Drug Administration is exploring importation to create more competition in the generics market.

These reforms will help. But the real game changer is under review at the Office of Management and Budget. Although details are under wraps, it is clear that Health and Human Services Secretary Alex Azar wants to end kickbacks in the pharmacy distribution chain that are costing Medicare and taxpayers billions of dollars.

Read Washington Post article